Lupus clinical trials in Michigan
10 studies for Lupus are looking for participants at sites in Michigan.
Cities in Michigan
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
- Revive Research Institute, Sterling Heights
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 25, 2026 · NCT07438496A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
- AA MRC LLC - Grand Blanc, Grand Blanc
- June DO, PC, Lansing
RecruitingPhase 2
Ages 18 to 74 · All sexes · Updated Sep 17, 2026 · NCT07409181A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
- Oakland Hills Dermatology, Auburn Hills
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 14, 2026 · NCT07355218A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
- Revival Research Institute, LLC, Troy
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 11, 2026 · NCT07332481A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50219, Detroit
RecruitingPhase 3
Ages 16 and older · All sexes · Updated Sep 4, 2026 · NCT06617325A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- Local Institution - 0034, Ann Arbor
- AA MRC, Grand Blanc
RecruitingObservational study
Ages 16 and older · All sexes · Updated Sep 3, 2026 · NCT07175285A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment
- Revive Research Institute, LLC, Sterling Heights
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Jul 30, 2026 · NCT07201129A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
- Investigative Site, Flint
- Investigative Site, Troy
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Jul 27, 2026 · NCT07260877Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
- Henry Ford Health, Detroit
- Ahmed Arif Medical Research Center, Grand Blanc
RecruitingPhase 3
Ages 12 to 100 · All sexes · Updated Jul 8, 2026 · NCT06133972Brief Pain Exposure Therapy (BPET) For Nociplastic Pain
- University of Michigan, Ann Arbor
Recruiting
Ages 18 and older · All sexes · Updated May 11, 2026 · NCT06208514From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.